United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59726-174_2099e3fb-d761-4735-9935-c51413496741
- Product NDC
- 59726-174
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Naproxen Sodium
- Labeler
- P & L Development, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180401 / 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 BOX (59726-174-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 59726-174-20
- 1 BOTTLE, PLASTIC in 1 BOX (59726-174-80) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 59726-174-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →